Vericel (VCEL) Total Debt (2010 - 2018)
Vericel (VCEL) reported Total Debt of $17.3 million for Q3 2018, up 73.55% on a YoY basis from $10.0 million in Q3 2017, and little changed sequentially from $17.3 million in Q2 2018.
Vericel (VCEL) Total Debt (2010 - 2018) Analysis & Trends
Vericel (VCEL) has 9 years of Total Debt data on file, last reported at $17.3 million in Q3 2018.
- For the quarter ending Q3 2018, Total Debt rose 73.55% year-over-year to $17.3 million; the trailing twelve-month figure through Sep 2018 stood at $17.3 million (up 73.55% YoY), and the FY2017 full-year result was $17.2 million, up 2025.52% from the prior year.
- Total Debt steadied at $17.3 million in Q3 2018, from $17.3 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $17.3 million in Q3 2018 to a low of $2000.0 in Q1 2014.
- A 5-year average of $5.8 million and a median of $811000.0 in 2016 frame the typical range for Total Debt.
- Across the five-year window, Total Debt tumbled 96.36% in 2015 and jumped 19423.08% in 2017, its largest moves.
- Tracing VCEL's Total Debt over 5 years: stood at $457000.0 in 2014, then plunged by 84.46% to $71000.0 in 2015, then surged by 1042.25% to $811000.0 in 2016, then surged by 2025.52% to $17.2 million in 2017, then grew by 0.24% to $17.3 million in 2018.
- Business Quant data shows VCEL's Total Debt at $17.3 million in Q3 2018, $17.3 million in Q2 2018, and $17.2 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 17.28 Mn |
| Jun 30, 2018 | 17.26 Mn |
| Mar 31, 2018 | 17.25 Mn |
| Dec 31, 2017 | 17.24 Mn |
| Sep 30, 2017 | 9.96 Mn |
| Jun 30, 2017 | 10.15 Mn |
| Mar 31, 2017 | 10.13 Mn |
| Dec 31, 2016 | 811,000.00 |
| Sep 30, 2016 | 5.61 Mn |
| Jun 30, 2016 | 52,000.00 |
| Mar 31, 2016 | 62,000.00 |
| Dec 31, 2015 | 71,000.00 |
| Sep 30, 2015 | 81,000.00 |
| Jun 30, 2015 | 91,000.00 |
| Mar 31, 2015 | 100,000.00 |
| Dec 31, 2014 | 457,000.00 |
| Sep 30, 2014 | 153,000.00 |
| Jun 30, 2014 | 2.50 Mn |
| Mar 31, 2014 | 2,000.00 |
| Dec 31, 2013 | 6,000.00 |